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ABSTRACT Recent reports have established the escalating threat of carbapenem-
resistant Enterobacter cloacae complex (CREC). Here, we demonstrate that CREC has
evolved as a highly antibiotic-resistant rather than highly virulent nosocomial patho-
gen. Applying genomics and Bayesian phylogenetic analyses to a 7-year collection of
CREC isolates from a northern Manhattan hospital system and to a large set of pub-
licly available, geographically diverse genomes, we demonstrate clonal spread of a
single clone, ST171. We estimate that two major clades of epidemic ST171 diverged
prior to 1962, subsequently spreading in parallel from the Northeastern to the Mid-
Atlantic and Midwestern United States and demonstrating links to international sites.
Acquisition of carbapenem and fluoroquinolone resistance determinants by both
clades preceded widespread use of these drugs in the mid-1980s, suggesting that
antibiotic pressure contributed substantially to its spread. Despite a unique mobile
repertoire, ST171 isolates showed decreased virulence in vitro. While a second clone,
ST78, substantially contributed to the emergence of CREC, it encompasses diverse
carbapenemase-harboring plasmids, including a potentially hypertransmissible IncN
plasmid, also present in other sequence types. Rather than heightened virulence,
CREC demonstrates lineage-specific, multifactorial adaptations to nosocomial envi-
ronments coupled with a unique potential to acquire and disseminate carbapenem
resistance genes. These findings indicate a need for robust surveillance efforts that
are attentive to the potential for local and international spread of high-risk CREC
clones.
IMPORTANCE Carbapenem-resistant Enterobacter cloacae complex (CREC) has emerged
as a formidable nosocomial pathogen. While sporadic acquisition of plasmid-encoded
carbapenemases has been implicated as a major driver of CREC, ST171 and ST78 clones
demonstrate epidemic potential. However, a lack of reliable genomic references and
rigorous statistical analyses has left many gaps in knowledge regarding the phyloge-
netic context and evolutionary pathways of successful CREC. Our reconstruction of
recent ST171 and ST78 evolution represents a significant addition to current under-
standing of CREC and the directionality of its spread from the Eastern United States
to the northern Midwestern United States with links to international collections. Our
results indicate that the remarkable ability of E. cloacae to acquire and disseminate
cross-class antibiotic resistance rather than virulence determinants, coupled with its
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ability to adapt under conditions of antibiotic pressure, likely led to the wide dis-
semination of CREC.
KEYWORDS antimicrobial resistance, bacterial evolution, bacterial genomics,
carbapenem resistance, Enterobacter cloacae
Carbapenem-resistant Enterobacteriaceae (CRE) represent a substantial threat tomodern health care, challenging our present antibiotic armamentarium and in-
creasing mortality and health care costs, particularly among chronically ill and immu-
nocompromised patients (1). In the United States, Klebsiella pneumoniae bacteria,
particularly the widespread health care-associated ST258 clone, have accounted for
the majority of CRE infections since their initial detection in the early 2000s (2).
However, reports of recent studies from throughout the United States have docu-
mented the expanding distribution of carbapenem-resistant Enterobacter cloacae com-
plex (CREC) (3–11), while the incidence of carbapenem-resistant K. pneumoniae resis-
tance has remained stable or has declined in some areas (7, 10, 12). Overall, the
genomic background of CREC is characterized by high clonal diversity (7, 8). However,
accumulating evidence suggests the widespread distribution and epidemic potential of
two high-risk CREC clones, ST171 and ST78 (4–7). In most studies, ST171 and ST78
isolates harbored the plasmid-encoded K. pneumoniae carbapenemase (KPC), while
diverse resistance mechanisms were detected in other clonal backgrounds (7, 8). Taken
together, these data suggest that the emergence of CREC has a complex history, driven
in part by its ability to acquire and maintain blaKPC-harboring plasmids.
Whole-genome sequencing (WGS) has demonstrated the development of CREC
clonal outbreaks superimposed on a background of diverse multidrug-resistant (MDR)
lineages. A WGS study of MDR E. cloacae in the United Kingdom and Ireland revealed
substantial heterogeneity among patterns of clonal spread and emergence of antibiotic
resistance but included very few carbapenem-resistant isolates (13). WGS analysis of
a localized CREC outbreak in Minnesota and North Dakota was consistent with a clonal
outbreak of ST171 associated with an IncFIA plasmid harboring blaKPC-3 (6). More
recently, Chavda et al. explored the phylogenetic structure of geographically diverse
carbapenem-resistant and carbapenem-susceptible Enterobacter spp., demonstrating
diverse mechanisms of resistance driven largely by horizontal transfer of blaKPC-
harboring plasmids followed by clonal spread (8). However, to date, little has been
known about the timeline of the recent evolution of CREC and its dominant clones in
the context of the introduction of carbapenems in the mid-1980s. Additional gaps in
knowledge, including the unique genetic features of ST171 and ST78 and their poten-
tial impact on the success of these two high-risk clones, could have important clinical
and infection control implications. Here we aimed to elucidate the genomic epidemi-
ology of CREC at a New York City hospital and to investigate the evolutionary relation-
ships between ST171 and ST78 genomes in New York City and geographically diverse
locations. Using whole-genome phylogenetic and phylogeographic analyses, we as-
sessed the spatiotemporal spread and distribution of mobile genetic elements (MGEs)
within ST171 and ST78 clonal sublineages. We also considered the potential contribu-
tion of resistance and virulence determinants to the recent emergence of CREC in the
United States and worldwide.
RESULTS
Population structure of Enterobacter cloacae complex isolates at a New York
City hospital. To assess the diversity of 125 E. cloacae complex isolates collected at a
northern Manhattan hospital system, we constructed a phylogenetic tree based on core
genome single nucleotide polymorphisms (SNPs) (Fig. 1). Isolates were distributed
across 30 different sequence types (STs), predominately ST171 (n  60) and ST78 (n 
25). Most isolates belonged to hsp60 clusters previously shown to be pathogenic in
humans, including cluster VI (ST171), cluster III (ST78), and cluster VIII (14, 15). The
remaining isolates were highly diverse and belonged to six different hsp60 clusters,
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including several rarely associated with human infection. Within each cluster, E. cloacae
complex isolates demonstrated variable phenotypic resistance to different antibiotic
classes (Fig. 1), although ST171 and, to a lesser extent, ST78 demonstrated remarkable
cross-class antibiotic resistance.
Emergence and regional spread of CREC ST171. In an analysis of the evolutionary
history of the ST171 clone, we mapped 144 ST171 sequences to the E. hormaechei
34978 reference genome (GenBank accession number CP012165) (8) and included 84
publically available genomes to provide temporal and geographic context (see Ta-
ble S2 in the supplemental material). A total of 1,659 core genome SNPs were identified
and used to construct a maximum likelihood phylogenetic tree (Fig. 2A). ST171 core
genomes were separated by 0 to 403 SNPs, indicating that many isolates were closely
related. Using Bayesian phylogenetic analysis of isolates demonstrating evidence of
clocklike evolution (n  106), we estimated a substitution rate of ~2.7 SNPs per year
(95% highest posterior density [HPD], 2.5 to 3.0), corresponding to a rate of 6.0  107
substitutions per nucleotide site per year. This estimate is comparable to that corre-
sponding to a recently described collection of MDR E. cloacae isolates from the United
FIG 1 Phylogenetic tree of multidrug-resistant Enterobacter cloacae complex and clustering by MLST and hsp60 sequencing. A maximum
likelihood tree of 125 Enterobacter cloacae complex isolates was constructed based on core genome concatenated SNPs. Corresponding
isolate MLST, hsp60 gene cluster, and carbapenemase allele data are shown in the three inner circles, with groups denoted by different
colors as indicated. While ST171/hsp60 cluster VI and ST78/hsp60 cluster III dominated among CREC and ESBL isolates, respectively, a
diverse subset of isolates was also seen. Isolate resistance profiles, including carbapenem resistance phenotype (CREC versus ESBL) and
resistance to 6 other major antibiotics, are shown in concentric circles on the outer periphery of the tree. ST171 isolates displayed
remarkable cross-class antibiotic resistance and were uniformly susceptible only to amikacin. In contrast, ST78 CREC isolates were
susceptible to levofloxacin. TMP/SMX, trimethoprim-sulfamethoxazole.
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FIG 2 Evolution of predominant CREC clone ST171. (A) A maximum likelihood tree of ST171 core genomes constructed using RAxML, including sequences of
isolates collected at our northern Manhattan hospital as well as published genomes from other geographic locations inside and outside the United States,
indicates the presence of the 2 major clades (clades A and B). Geographic location is denoted by branch colors. Annotations from the inner to the outer rows
include blaKPC allele, replicon type of the putative blaKPC-harboring plasmid, and heat maps depicting percent alignment of Illumina reads to mobile genetic
elements detected on ST171 reference genome 34978, including (from left to right) genomic island 1 (GI1) to GI8 and phage regions 1 to 6, for each ST171
isolate. Additional details regarding GIs and phage regions can be found in Table S4. While clade A comprised mostly blaKPC-4-harboring isolates, clade B was
largely defined by blaKPC-3 carriage and included instances of local regional spread. Links to international isolates are indicated in both branches. (B and C) We
also used BEAST analysis to map the phylogeny of ST171 (B), demonstrating multiple introductions of blaKPC in this clone, as well as to further delineate the
geotemporal emergence of the major ST171 clades (C). Branches are scaled by time (year-month). Support at each node is reflected by the size and color of
the shapes at each junction. In panel B, arrows indicate branches with all daughter nodes containing blaKPC-4 or blaKPC-3, with the exception of 3 isolates marked
with symbols (*, KPC-negative isolates; , blaKPC-2-containing isolate).
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Kingdom and Ireland, for which an average of 1.5  107 substitutions per nucleotide
site per year across the genome (0.5 to 3.0 SNPs per year) was reported (13). ST171
isolates clustered into two major clades (clades A and B) which we estimate diverged
prior to 1962 on the basis of the derived substitution rate (Fig. 2B).
Clade A, comprising approximately 10% of ST171 genomes, consisted of isolates
originating from diverse geographic sites, including New York City, Boston, Brazil, and
the United Kingdom (Fig. 2A). Isolates belonging to clade A either possessed blaKPC-4
(n  9) or were blaKPC negative (n  2). blaKPC-4-harboring isolates formed a distinct
branch with a common ancestor dating to 1993 (posterior probability [PP]  0.999)
(Fig. 2B), which predates the first detection of CRE in the United States, in 1996 (16).
Clade B consisted of two large clusters of closely related isolates from northern
Manhattan and the northern Midwest, including Minnesota and North Dakota, as well
as isolates from the United Kingdom, Boston, New York City, New Jersey, Pennsylvania,
and Michigan. While most ST171 CREC isolates from clade B harbored blaKPC-3 (n 
124), sporadic isolates possessed blaKPC-2 (n  2) or were KPC negative (n  4).
According to results of analysis of the ancestral nodes, blaKPC-3-harboring isolates
shared one recent common ancestor, which emerged prior to 2002 (PP  1). Recon-
struction of whole-genome phylogeny by the use of Gubbins software revealed that
ST171 clade B was additionally defined by several small recombination events (see
Fig. S1 in the supplemental material). A 70-kb recombination region encoded a total of
80 proteins, including several proteins involved in DNA replication and 7 different
conjugal transfer proteins (Table S3). Within each clade, we also found evidence for the
development of fluoroquinolone resistance accompanied by the acquisition and es-
tablishment of mutations in the gyrA (g.248CT, g.260AC) and parC (g.239GT)
genes (17).
Phylogeographic Bayesian analysis of U.S. isolates with defined collection locations
and evidence for clocklike evolution (n  107) suggests that both clade A and clade B
originated in Boston and spread to other regions within the United States (PP  0.89)
(Fig. 2C). From Boston, clade A likely spread to New York City whereas clade B spread
to the New York-New Jersey area (PP  0.95) and subsequently to New York City (PP 
0.88) and the northern Midwest (PP  0.93) between 2007 and 2008 (Fig. 2B). This was
followed by local proliferation within the northern Manhattan and northern Midwest-
ern sites with occasional cross-regional links.
ST78 is defined by distinct CREC and extended-spectrum-beta-lactamase
(ESBL)-producing sublineages. Due to the lack of publicly available ST78 reference
genomes, we generated a de novo hybrid assembly for NR0276 using Illumina short
reads scaffolded with nanopore reads. The resulting NR0276 genome consisted of 2
chromosomal contigs with an average coverage of 83, in addition to three complete
plasmids assembled into single contigs (Whole Genome Shotgun Project accession
number PNXT00000000). We mapped sequencing reads from 25 northern Manhattan
isolates and 20 published ST78 genomes from Boston to this new reference sequence
in order to reconstruct the evolutionary history of ST78 (Table S2). We identified and
used 1,235 SNPs in the core chromosome to build a maximum likelihood phylogenetic
tree (Fig. 3A). Pairwise SNP distances between ST78 isolates ranged from 0 to 421. We
observed two major clades as confirmed through Bayesian phylogenetic analysis of
isolates with clocklike evolution (n  27) (Fig. 3B). On the basis of an estimated
substitution rate of ~4.3 SNPs per year (95% HPD, 3.7 to 5.0), these distinct clades
diverged well before 1984 (PP  1), although a lack of earlier isolates precludes
improved resolution of the date of divergence (Fig. 3B). Notably, the branch lengths
separating these two clades and the length of time since divergence could not be
linked to a major recombination event (Fig. S2).
Clade A, consisting of approximately 10% of the ST78 isolates (n  5), was com-
posed exclusively of CREC isolates from northern Manhattan harboring blaKPC-3
(Fig. 3A). The second, larger clade, which included isolates from both New York and
Boston, consisted of several distinct subclades (subclades B, C, and D, Fig. 3A) defined
by beta-lactamase carriage. Subclade B was composed of New York isolates containing
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blaKPC-2 (n  4), while subclade C (n  15) was defined by blaKPC-4 carriage and
included both New York and Boston isolates. Subclade D, consisting of carbapenem-
susceptible isolates (n  16) harboring the ESBL blaCTX-M-15 gene, was interspersed with
three sporadic carbapenem-resistant isolates, of which two were carbapenemase neg-
ative and one demonstrated uptake of blaKPC-3. Unlike the isolates in clade A, isolates
in subclades B, C, and D were resistant to fluoroquinolones and were found to
have missense mutations in the gyrA (g.247_248TCAT), parC (g.239GT), and acrB
(g.215GA) genes (17).
blaKPC-3-harboring ST78 CREC clade A had a most recent common ancestor dated at
1985 as suggested through Bayesian reconstruction (PP  0.999) (Fig. 3B). Low sample
size precluded confidence in the dating of the most recent common ancestor of
blaKPC-2-containing subclade B, while subclade C, defined by blaKPC-4 carriage, had an
ancestral node dated at 1997 (PP  1). blaCTX-M-15-containing subclade D had a most
recent common ancestor which Bayesian reconstruction suggested dates to 2000 (PP 
1) and likely diverged from subclades B and C in 1984 (PP  0.999).
Repertoire of mobile genetic elements (MGEs) of ST171 and ST78 genomes.
MGEs unique to ST171 and ST78 genomes encoded a variety of adaptive mechanisms
potentially enabling their success within hospital environments. Of eight predicted
MGEs in ST171 reference genome 34978, three were distributed throughout both
clades (Fig. 2A). A 30-kb genomic island (GI) (GI3; Table S3) unique to ST171 comprised
31 coding sequences (CDS), including a putative type IV toxin-antitoxin (TA) gene pair
FIG 3 Phylogeny of ST78, including ESBL and blaKPC-harboring isolates. (A) A RAxML tree of ST78 genomes also demonstrated the presence of two major
sublineages, one composed exclusively of isolates harboring blaKPC-3 (clade A) and one comprising separate ESBL and blaKPC-harboring subclades B, C, and D.
Geographic location is again denoted by branch colors. Annotations from the inner to the outer rows include blaKPC allele, replicon type of the inferred
blaKPC-harboring plasmid, and percent alignment of isolate short reads to mobile genetic elements, including (from left to right) genomic island (GI) GI1 to GI10
and phage regions 1 and 2 detected on the NR0276 reference genome. Additional details regarding mobile genetic elements can be found in Table S4. (B)
BEAST analysis demonstrated the initial divergence of a distinct carbapenem-resistant clade followed by separation of the predominantly ESBL and other CREC
sublineages defined by carriage of different beta-lactamase genes. These two main sublineages were also distinguished by the presence of missense mutations
in gyrA (g.247_248TCAT), parC (g.239GA), and acrB (g.215GA) in clade A conferring fluoroquinolone resistance, which were not seen other ST78 isolates.
Support at each node is denoted by the size and color of shapes at each junction.
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encoding cytoskeleton-binding toxin (CbtA) and cytoskeleton bundling-enhancing
factor A (CbeA), which are thought to participate in cellular stress responses (18). Five
additional genomic islands present only in ST171 clade B encoded several putative
virulence factors, including arsenic resistance genes from the ars arsenic resistance
operon (GI1) (19) and a cluster of genes encoding copper-binding and resistance
proteins and belonging to the cop operon (GI2) (20). The ST171 reference genome also
harbored six different phage regions, five of which were found throughout both clades
(Fig. 2A). The 70-kb HK639 bacteriophage (Phage3; Table S3) putatively encoded an
alpha-hemolysin, although this phage was limited to a small subset of ST171 isolates
from New York City within clade B and was absent from other CREC clonal back-
grounds.
Five of 10 genomic islands identified in the NR0276 ST78 reference genome were
present in all ST78 isolates. These genomic islands encoded a variety of potential
virulence factors, including a gene cluster encoding S-fimbrial adhesin proteins (GI1)
(21) and the flagellin protein FliC and associated flagellar export and regulatory
proteins (GI5) (22). However, the other five NR0276 genomic islands were present only
in blaKPC-3-harboring clade A. This included GI6, a large genomic island (80 kb)
composed of 61 CDS encoding the type II TA system PasT/PasI, which has been shown
to enable pathogen persistence in limited-nutrient settings and in the face of oxidative
and nitrosative stress in Escherichia coli (23). Genes involved in silver and copper
sequestration and resistance, including components of the sil, cus, and cop operons,
were also identified in a genomic island (GI9) associated with this clade (20, 24). The
ST78 reference genome contained two phage regions, HK639 (Phage1) and the wide-
spread 40-kb mEp390 bacteriophage (Phage2), which was present in most ST78 ge-
nomes as well as ST171 genomes.
Plasmid-encoded antimicrobial resistance genes. The presumed mechanism of
carbapenem resistance in almost all CREC isolates regardless of clonal background was
carriage of blaKPC-harboring plasmids (87%), although 1 CREC isolate harbored blaNDM-1
and 12 isolates lacked detectable carbapenemase genes. In order to determine the
genetic context of blaKPC in ST171 and ST78 isolates, we generated de novo hybrid
assemblies of plasmids from representative isolates belonging to the major CREC ST171
and ST78 clades (Table S5). However, in non-ST171/ST78 isolates, particularly those
harboring blaKPC-2 (n  9), blaKPC was associated with variable plasmid profiles and in
most cases could not be assigned to plasmid backbones using short-read data.
In ST171 clade A isolates, blaKPC-4 was present on an IncHI2A/IncHI2 plasmid
(Fig. 2A). De novo assembly identified a large (315-kb) representative plasmid, pNR3082,
which harbored blaKPC-4 within Tn4401b, an additional beta-lactamase gene, and
aminoglycoside and sulfonamide resistance genes. The majority of ST171 clade B
isolates putatively harbored an IncFIA plasmid harboring blaKPC-3, consistent with
clonal spread (Fig. 2A). Representative 141-kb IncFIA plasmid pNR3024 contained the
blaKPC-3 gene within Tn4401d as well as two additional beta-lactamase genes and
several aminoglycoside and sulfonamide resistance genes (Fig. 4A). The backbone
structures of pNR3024 were highly similar to those of p34798, an IncFIA plasmid
derived from the 34978 reference genome, and pBK30683 in K. pneumoniae, which was
previously shown to be widely distributed in hospitals in New York and New Jersey
(Fig. 4; see also Table S5) (25). pNR3024 differed from these plasmids by 80 SNPs
distributed in methyltransferase genes and genes associated with hypothetical pro-
teins, a 98-bp insertion in the DNA polymerase III theta subunit of pNR3024, and an
inverted 7.5-kb region distal to blaTEM-1 harboring an aminoglycoside resistance gene
(Fig. 4). IncFIA plasmid pMNCRE44, which was identified among ST171 isolates in the
northern Midwest (6), also shared a similar plasmid backbone consisting of three
collinear blocks with close identity that resulted in approximately 60% homology with
pNR3024 (Fig. 4), suggesting recent diversification.
Although ST78 included fewer CREC isolates, we found evidence for multiple distinct
blaKPC-encoding plasmids in this clonal lineage (Fig. 3A). Most clade A CREC isolates
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harbored an IncN plasmid represented by pNR0276, a 69-kb plasmid containing blaKPC-3
within a Tn4401b transposon (Fig. 4B; see also Table S5). pNR0276 was also detected in
three isolates belonging to unique STs (ST93, ST133, and ST269) and hsp60 clusters,
indicating a broad host range. pNR0276 closely resembled the IncN pKm38_N plasmid
from a Klebsiella michiganensis strain harboring blaKPC-2 collected in 1997 (Fig. 4B) (26),
differing by only 22 SNPs and a 210-bp transposase deletion. In subclades B and C,
respectively, blaKPC-2 and blaKPC-4 were putatively located on distinct and yet related
plasmids which shared an IncN replicon type and contained conserved backbone
structures (Fig. 3A) (5, 8). The evidence for conserved elements in IncN plasmid
harboring different blaKPC subtypes was further demonstrated by alignment of
pNR0276 to pBK31551 and blaKPC-4-harboring IncN plasmid derived from a K. pneu-
moniae isolate from a New Jersey hospital (27), which revealed the presence of three
large collinear blocks with a total length of approximately 50 kb demonstrating 95%
identity (Fig. 4B). We also found evidence in our collection for horizontal transfer of a
pNR3024 plasmid from ST171 to ST78, as two closely related ST78 isolates obtained
from the same patient 1 month apart (patient A, Table S1) differed only by the presence
of this IncFIA plasmid.
To determine the in vitro transmissibility of plasmids from distinct CREC back-
grounds, we determined transformation efficiencies for IncFIA and IncN plasmids.
IncFIA plasmids were derived from a representative isolate within the major northern
Manhattan cluster of ST171 clade A (pNR0011) as well as from outlying branches
FIG 4 Genetic features of ST171 IncFIA plasmids. (A) The sequence of a representative 139-kb IncFIA
plasmid harboring blaKPC-3 found in an ST171 clade B isolate, pNR3024, was compared to sequences of
plasmids from E. cloacae complex reference isolates P34978 and pMNCRE41-2 and K. pneumoniae
pBK30683. The areas of light green shading depict regions of homology, and resistance and other predicted
genes are denoted as indicated. (B) A 69-kb IncN plasmid harboring blaKPC-3, represented by pNR0276,
demonstrated close identity to the IncN pKm38_N plasmid, with the notable exception of a single SNP in
blaKPC consistent with a change in subtype. These IncN plasmids demonstrated regions of homology shared
with blaKPC-4-harboring IncN plasmid pBK31551.
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(pNR3040 and pNR3041). We also selected IncN plasmids from ST78 clade A (pNR3055)
and from different STs (pNR1247 and ST454). We transformed these plasmids into E. coli
DH10B cells and observed a significant difference in mean transformation efficiencies
between the IncN pNR1247 plasmid and the IncFIA pNR0011_1 plasmid (7.2 
104 CFU/l [standard deviation {SD}, 6.5  103] versus 1.2  103 [SD, 1.4  103]; P 
0.01) (Fig. S3). Intermediate values were observed for IncFIA plasmids pNR3040 and
pNR3041 and IncN plasmid pNR3055.
CREC is a low-virulence pathogen. To evaluate differences in virulence between
CREC clones and between CREC and ESBL isolates, we employed a cytotoxicity assay
using immortalized, bone marrow-derived murine macrophages. Macrophages ex-
posed to cell-free bacterial supernatant derived from CREC isolates compared to ESBL
isolates demonstrated a significant difference in the levels of cell killing (median versus
maximum lactate dehydrogenase [LDH] release, 7.6% versus 21.0%, P  0.04) (Fig. 5A).
Compared to ST78 isolates, ST171 isolates showed reduced cytotoxicity, although the
difference was not significant (6.5% versus 21.0%, P 0.052) (Fig. 5B). However, the
FIG 5 Differences in levels of cell killing among CREC and ESBL Enterobacter isolates. The data represent pooled median values for percentages of maximum
LDH release compared to Triton X results after exposing murine macrophages to bacterial supernatant. The group median and interquartile range (IQR) are
shown. Asterisks (*) denote significance (P  0.05). (A) Overall, CREC isolates demonstrated significantly lower cytotoxicity than ESBL isolates (7.6% [IQR, 4.0 to
21.7] versus 21.0% [IQR, 5.0 to 34.5], P  0.04). (B) There was a nonsignificant trend toward decreased cytotoxicity between ST171 and ST78 isolates (6.5% [IQR,
2.3 to 20.9] versus 21.0% [IQR, 5.1 to 29.9], P  0.052), while other STs demonstrated heterogeneity in cell killing (median, 10.6 [IQR, 3.0 to 23.3]). (C) There was
no significant association between cytotoxicity and blaKPC subtype among CREC isolates (overall P  0.1). (D) Likewise, levels of cell killing did not differ
significantly across culture sources (overall P  0.2).
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subset of CREC ST171 isolates showed significantly lower toxicity than the ESBL ST78
isolates (6.0% versus 21.5%, P  0.007). There were no significant differences in the
levels of cell killing in comparisons of isolates from different ST171 and ST78 clades
(overall P  0.2). We also noted no significant differences in the levels of cytotoxicity
between ST171 and non-ST171/ST78 isolates (6.5% versus 10.6%, P  0.8), although the
latter produced variable levels of cell killing (Fig. 5B). There were no significant
differences in cytotoxicity among the isolates based on culture source or blaKPC subtype
(Fig. 5C and D).
DISCUSSION
In this comprehensive collection of newly sequenced CREC isolates and published
genomes, we found evidence for five putative mechanisms of CREC evolution and
dissemination (summarized in Fig. 6). These included (i) independent acquisition of
blaKPC in ST171 by at least two distinct clonal sublineages with subsequent clonal
spread and regional outbreaks; (ii) multiple instances of blaKPC uptake into a dominant
ESBL clone, ST78; (iii) distribution of an IncN plasmid among several different STs,
indicating a possible hypertransmissible plasmid; (iv) uptake of a variety of carbapen-
emase gene-harboring plasmids into diverse STs; and (v) sporadic emergence of
non-carbapenemase-producing isolates. Overall, the introduction of blaKPC into multi-
ple E. cloacae complex clones, including several distinct ST171 and ST78 sublineages,
suggests that a combination of species-specific and external factors, such as antibiotic
pressure, has contributed to the widespread emergence of CREC.
FIG 6 Proposed mechanisms of CREC evolution and dissemination. (A) Plasmid uptake followed by
clonal dissemination. ST171 was highly associated with an IncFIA plasmid found to harbor blaKPC-3 in a
representative isolate, suggesting that plasmid uptake followed by clonal dissemination was the dom-
inant mechanism of carbapenem resistance in this predominant clonal lineage. (B) Uptake of blaKPC-
harboring plasmids into a predominantly ESBL clone. ST78 demonstrated multiple independent plasmid
uptake events. (C) Uptake of diverse plasmids into sporadic clones. Independent events of plasmid
uptake into multiple different clones involved multiple different carbapenemase genes, including
blaKPC-2. (D) Dissemination of a hypertransmissible plasmid. We detected IncN plasmids harboring blaKPC-3
in several different clonal sublineages, suggesting that this may be a highly transmissible plasmid. (E)
Carbapenem resistance in non-carbapenemase-producing isolates. A subset of CREC isolates did not
harbor blaKPC or other known carbapenemases.
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Our study provided robust evidence for the spread of two distinct ST171 clades
across the United States, including a successful blaKPC-3-harboring sublineage demon-
strating multiple foci of rapid, regionalized clonal proliferation in the Northeastern and
northern Midwestern United States. Within the two clades, we also identified links
between isolates from different regional and international locations, highlighting the
potential for transmission of high-risk clones to contribute to the global spread of CRE.
Although results of in vitro experiments suggested that ST171 is a low-virulence
organism relative to other E. cloacae clones, ST171 isolates demonstrated remarkable
cross-class resistance to antibiotics used commonly to treat Gram-negative infections,
with the exception of amikacin. Notably, the acquisition of carbapenem and fluoro-
quinolone resistance determinants prior to widespread use of carbapenems and fluo-
roquinolones suggests that ST171 was already present in hospital settings prior to the
mid-1980s and may have proliferated in the setting of rising antibiotic pressure.
Conversely, the emergence of CREC ST78 was characterized by multiple instances of
sporadic uptake of blaKPC-harboring plasmids without evidence of extensive clonal
spread. We identified three different CREC subclades defined by different blaKPC
subtypes and a large sublineage of isolates from northern Manhattan demonstrating
update of the plasmid-mediated blaCTX-M-15 ESBL gene. Moreover, ST78 isolates har-
bored unique genetic factors that may make this clone particularly adept at thriving in
nosocomial environments, such as metal-binding and resistance proteins and genes
putatively enabling niche-specific colonization. Given that previous population analy-
ses of MDR E. cloacae demonstrated that ST78 is a widespread, globally dominant ESBL
clone (28, 29), this suggests that ST78 is a highly successful hospital-associated clone
with a unique ability to accept plasmids harboring resistance genes.
In addition to high-risk CREC clones, our findings suggest that increased attention
to plasmid-mediated transmission of blaKPC is also warranted. We found evidence for
recent horizontal transfer of a hypertransmissible IncN plasmid harboring blaKPC, which
was identified in multiple CREC clones and demonstrated relatively high in vitro
transformation efficiency. Among previous studies, IncN family plasmids were fre-
quently implicated in dissemination of blaKPC among multiple bacterial strains (30, 31).
Interestingly, pNR0276 was found to be closely related to blaKPC-harboring IncN
plasmids collected in the 1990s (26), further suggesting that it is a well-established
plasmid backbone with the potential to enable multispecies spread of blaKPC. However,
we also detected a wide diversity of CREC isolates harboring heterogeneous plasmids,
particularly among blaKPC-harboring isolates. This may be driven by a growing hospital
reservoir of blaKPC-harboring plasmids as well as intrinsic factors that enable rapid
uptake and acquisition of novel plasmids in E. cloacae complex.
Our study had several notable limitations. Our sample size was limited to available
clinical CREC isolates at our hospital system and to published CREC genomes and may
have reflected oversampling of clonal outbreaks. In order to perform Bayesian phylo-
genetic and phylogeographic analyses, several assumptions were required, and inher-
ent limitations of these techniques may have introduced uncertainty into our findings.
The accuracy of the evolutionary timeline for both ST171 and ST78 would be improved
by the availability of more-recent clinical isolates or of additional earlier isolates
collected prior to the early 2000s. Although we demonstrated high node support at all
primary branch points in our analyses, the availability of additional isolates may lead to
improved resolution of both recent branches with low support and long branches
which could not be resolved due to a lack of earlier isolates. Moreover, our phylogeo-
graphic analysis was limited by the availability of isolates from only a few health care
facilities and, more broadly, by the inclusion of isolates from only the Northeastern and
northern Midwestern United States. Ultimately, phylogeographic analysis will produce
a tree rooted in one of the sampled locations. Therefore, despite our high statistical
support for the idea of an origin of ST171 in Boston, the future inclusion of isolates from
additional locations may either support or refute this finding. Lastly, our cytotoxicity
model was limited to demonstrating cytolytic activity of bacterial supernatant and may
not fully reflect the in vivo virulence profile of CREC clones. In vivo models and
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functional studies are needed to further explore the role of specific genomic determi-
nants in shaping the distribution and success of ST171 and ST78.
In summary, here we elucidated diverse evolutionary pathways of high-risk and
sporadic E. cloacae clones in a large data set of genomes from across the United States
and international sites. The inclusion of long-read sequencing and de novo hybrid
assemblies, including new genomic and plasmid reference sequences, minimized
reference bias and enabled detailed analysis of lineage-specific MGE and resistance
gene repertoires. Our results indicate that, rather than heightened virulence, it was
likely the proclivity of E. cloacae to acquire and disseminate multidrug resistance
determinants, coupled with its ability to adapt to nosocomial environments, that led to
the wide dissemination of CREC. The clonal expansion of ST171 across the United States
and its subsequent local proliferation point to the need to pay increased attention to
this high-risk clone. However, ongoing uptake of blaKPC-harboring plasmids has the
potential to generate new CREC sublineages in ST78 and other E. cloacae complex
subtypes. This indicates a need for heightened surveillance efforts attentive to the
potential for both local and international spread of high-risk clones and the emergence
of new CREC sublineages.
MATERIALS AND METHODS
Selection of bacterial isolates. We sequenced 125 MDR E. cloacae complex isolates collected
between November 2009 and July 2016 at a tertiary care hospital in northern Manhattan (see Table S1 in
the supplemental material). This collection encompassed all available CREC isolates, including 46 isolates
for which clinical and genotyping data were described previously (7), and a subset of ESBL isolates
belonging to ST78 or ST171 for comparison. We obtained clinical and microbiological data from a review
of electronic health records and ascertained colonization status versus infection status using CDC
National Healthcare Safety Network surveillance definitions (32). Antimicrobial susceptibilities were
determined using Vitek2 or Etest (BioMérieux) as part of routine clinical care and interpreted using
Clinical and Laboratory Standards Institute breakpoints (33). We identified an additional 104 publicly
available CREC genomes for inclusion in the analysis (Table S2).
Whole-genome sequencing and hybrid assembly. Genomic DNA was extracted using a DNeasy
UltraClean microbial DNA isolation kit (Qiagen). Index-tagged whole-genome libraries were sequenced
using a HiSeq 2500 system (Illumina) and a MiSeq system (Illumina). We also conducted long-read
sequencing for representative ST171 and ST78 isolates. DNA library preparation was performed using a
Rapid Barcoding sequencing kit (Oxford Nanopore Technologies). Sequencing was then performed using
a MinION DNA sequencer (Oxford Nanopore Technologies), and preprocessing of long reads with
Poretools was performed as previously described (34, 35). Hybrid de novo assembly performed with
SPAdes v3.10.1 (36) was followed by contig reordering using progressiveMauve in Geneious v10.0.5 (37)
and annotation using Prokka v1.12 (38) and BLAST as previously described (35). Mobile genetic elements
(MGEs) and prophage regions were identified by IslandViewer 3 (39) and PHAST (40), respectively.
Gubbins v2.3.1 was used to identify possible recombination sites (41).
Isolates were classified by cluster membership (in clusters I to XI) based on hsp60 housekeeping gene
typing (14) as well as on multilocus sequence typing (MLST) (42), antimicrobial resistance gene profiling
(43), and plasmid replicon typing (44) using SRST2 (45). To identify sublineage-specific MGEs, we used
bowtie2 v2.3.1 (46) to align short reads against MGEs present in the ST171 and ST78 reference genomes,
with no ambiguous matches permitted. Alignment lengths were tabulated using SAMtools v1.5 (47), and
MGE presence was defined as alignment of 95% of MGE lengths. Putative plasmid presence was
determined based on identification of replicon type and blaKPC subtype using BLAST, as well as mapping
of Illumina reads to reference plasmid sequences in Geneious v8.1.7 (48). Plasmids demonstrating at least
99% identity over 90% of the sequence length, including the replicon regions and the entire Tn4401
transposon (49), were classified as closely related.
Phylogenetic analysis. We constructed phylogenetic trees by mapping individual genomes to
ST171 and ST78 reference genomes to identify core genome single nucleotide polymorphisms (SNPs)
using Snippy v3 (https://github.com/tseemann/snippy). Maximum likelihood phylogenetic analysis based
on core genome concatenated SNPs was performed using RAxML v8.0.0 (50). Support for nodes was
assessed using 100 rapid bootstrap inferences, and a final tree was selected through a maximum
likelihood search under Gamma (50). Phylogenetic trees were visualized using iTOL v3 (51).
We performed Bayesian analysis to estimate the time to the most recent ancestor for ST78 and ST171.
After all outliers were removed, a subset of ST171 and ST78 isolates displaying evidence of clock-like
evolution as determined through TempEst (52) were used to estimate the substitution rate, time of
emergence, and divergence dates within each clonal lineage using BEAST2 v2.4.7 (53–55). Using the HKY
substitution Gamma site model with a relaxed lognormal molecular clock and coalescent Bayesian
skyline prior, BEAST2 was run for 100 million generations, with sampling every 1,000 states and with
isolate collection dates defined as available. Tracer v1.6 was used to inspect chain convergence and
ensure an effective sample size (ESS) of 100 for all key estimated parameters (56). BEAST2’s Tree-
Annotator v2.4.7 was used to identify the maximum clade credibility tree after 10% burn-in.
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We also used Bayesian analysis to estimate the origins and phylogeographic spread of ST171 within
the United States, with tip dates defined as described above and location assigned to NYC, New Jersey,
Boston, or Minnesota/North Dakota. The BEAUti MultiTypeTree template was used to prepare the BEAST2
input using location as a discrete trait (57). The HKY substitution model and relaxed lognormal
molecular clock were used, with the clock rate set to the ST171 BEAST analysis estimate (2e3). The
MultiTypeTree structured coalescent prior was used with lognormal distributions of kappa, population
size, and rate matrix priors. The phylogeographic BEAST analysis was run for 400 million generations, with
sampling every 10,000 states, and was repeated three times to ensure convergence of chains and
sufficient ESS as calculated. LogCombiner v2.4.7 and Tree Annotator v2.4.7 were used to obtain a clade
tree with maximum credibility after combining trees from all three runs with 10% burn-in. FigTree v1.4.3
was used for visualization of all BEAST trees.
Microbiological characterization. The cytotoxicity of cell-free culture supernatant obtained from a
randomly selected subset of previously sequenced E. cloacae isolates (n  90) was assessed in vitro using
an immortalized murine bone marrow-derived macrophage (iBMDM) cell line. Once iBMDM cells were
grown to confluence in a 100-mm-diameter petri dish, they were subjected to trypsinization and seeded
the day before intoxication at 50,000 cells/well. Cultures grown overnight in Trypticase soy broth at 37°C
with shaking at 2,469  g were diluted to 1:100 and incubated for an additional 8 h. Bacterial
supernatant was then collected by centrifugation and incubated with murine macrophages for 2 h at
37°C in 96-well flat-bottom plates. Cell viability was assessed by measuring release of lactate dehydro-
genase (LDH), corrected for maximum LDH release by addition of Triton X to a control well. Cell viability
assays were performed on 10 different colonies on 4 different days and pooled for analysis. Median
differences in percentages of the maximum LDH release by Triton X were compared between isolate
groups using the Mann-Whitney test or the Kruskal-Wallis nonparametric test with Dunn’s correction for
multiple comparisons as appropriate, and data were visualized using GraphPad Prism v7.02 (GraphPad
Software, Inc.).
IncFIA and IncN plasmids, including plasmids derived from major CREC ST171 and ST78 sublineages,
were isolated and purified using a plasmid minikit (Qiagen) and were electroporated into competent
E. coli DH10B cells (Invitrogen) using a Gene Pulser Xcell system (Bio-Rad Laboratories). Transformants
were selected using LB agar plates containing 100 g/ml carbenicillin. Gel electrophoresis was used to
confirm plasmid sizes, and the presence of blaKPC was confirmed by PCR using established primers (58).
Transformation experiments were performed in triplicate, and efficiencies were calculated as the number
of transformants per microgram of competent cells.
Accession number(s). Sequence data were deposited in the NCBI sequence read archive (SRA)
(https://www.ncbi.nlm.nih.gov/sra) under accession numbers SRP099597 and SRP126514 (BioProjects
PRJNA374677 and PRJNA421733). Individual BioSample numbers for each isolate are provided in
Table S1. The NR0276, NR3024, and NR3082 hybrid assembly whole-genome shotgun projects have been
deposited at DDBJ/ENA/GenBank under accession numbers PNXT00000000, PNXS00000000, and
PNXR00000000, respectively. The versions described in this paper are PNXT01000000, PNXS01000000,
and PNXR01000000. Novel housekeeping gene allelic variants were reported to the E. cloacae MLST
database curator (http://pubmlst.org/ecloacae/).
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